相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small-Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 Protect Against Angiotensin II-Induced Vascular Dysfunction and Hypertension
Andrew W. Johnson et al.
HYPERTENSION (2013)
Biaxial vasoactivity of porcine coronary artery
Yunlong Huo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Tissue inhibitor of metalloproteinases (TIMPs) in heart failure
Linn Moore et al.
HEART FAILURE REVIEWS (2012)
Loss of Timp3 Gene Leads to Abdominal Aortic Aneurysm Formation in Response to Angiotensin II
Ratnadeep Basu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Effect of Novel Limited-Spectrum MMP Inhibitor XL784 in Abdominal Aortic Aneurysms
Terri Ennis et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Arterial stiffness identification of the human carotid artery using the stress-strain relationship in vivo
T. Khamdaeng et al.
ULTRASONICS (2012)
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats
Paulo W. Pires et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2
JiuChang Zhong et al.
HYPERTENSION (2011)
Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia
J. S. Morton et al.
JOURNAL OF APPLIED PHYSIOLOGY (2011)
Changes in the Mechanical and Biochemical Properties of Aortic Tissue due to Cold Storage
Ming-Jay Chow et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension
Michele M. Castro et al.
PHARMACOLOGICAL RESEARCH (2011)
Effects of Doxycycline on Production of Growth Factors and Matrix Metalloproteinases in Pulmonary Fibrosis
Hanako Fujita et al.
RESPIRATION (2011)
Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction
Vijay Kandalam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
TIMP2 Deficiency Accelerates Adverse Post-Myocardial Infarction Remodeling Because of Enhanced MT1-MMP Activity Despite Lack of MMP2 Activation
Vijay Kandalam et al.
CIRCULATION RESEARCH (2010)
Potential Therapeutic Targets for Cardiac Fibrosis TGFβ, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation
Andrew Leask
CIRCULATION RESEARCH (2010)
Interleukin 6 Knockout Prevents Angiotensin II Hypertension Role of Renal Vasoconstriction and Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Activation
Michael W. Brands et al.
HYPERTENSION (2010)
Angiotensin II-Induced Oxidative Stress Resets the Ca2+ Dependence of Ca2+-Calmodulin Protein Kinase II and Promotes a Death Pathway Conserved Across Different Species
Julieta Palomeque et al.
CIRCULATION RESEARCH (2009)
Angiotensin II: a regulator of cardiomyocyte function and survival
Julieta Palomeque et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Simultaneous Transforming Growth Factor β-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart
Zamaneh Kassiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis
Zamaneh Kassiri et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Vascular Extracellular Matrix and Arterial Mechanics
Jessica E. Wagenseil et al.
PHYSIOLOGICAL REVIEWS (2009)
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
Michele A. Castro et al.
ATHEROSCLEROSIS (2008)
Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States
Majid Ezzati et al.
CIRCULATION (2008)
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
Marcio L. L. Martinez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress
Jay D. Humphrey
HYPERTENSION (2008)
Progress in matrix metalloproteinase research
Gillian Murphy et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Angiotensin II:: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
K.-D. Schlueter et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness
Christine Armstrong et al.
STROKE (2007)
Role of matrix metalloproteinases in early hypertensive vascular remodeling
Martin Flamant et al.
HYPERTENSION (2007)
Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats
Stephanie W. Watts et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo:: Evidence of a pressure-independent effect
G. Castoldi et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with
Philip M. Cummins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome
John S. Ikonomidis et al.
CIRCULATION (2006)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Matrix metalloproteinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
Giuseppe Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
Individual Timp deficiencies differentially impact pro-MMP-2 activation
JL English et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Combination of tumor necrosis factor-α ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice
Z Kassiri et al.
CIRCULATION RESEARCH (2005)
Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition
C Bouvet et al.
HYPERTENSION (2005)
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness
Yasmin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo
G Castoldi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Selected major risk factors and global and regional burden of disease
M Ezzati et al.
LANCET (2002)
Doxycycline in patients with abdominal aortic aneurysms and in mice: Comparison of serum levels and effect on aneurysm growth in mice
AK Prall et al.
JOURNAL OF VASCULAR SURGERY (2002)
Local pulse pressure is a major determinant of large artery remodelling
S Laurent et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice
HS Ju et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix
WH Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure and mechanical properties of resistance arteries in hypertension - Role of adhesion molecules and extracellular matrix determinants
HD Intengan et al.
HYPERTENSION (2000)
分享论文
